医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Wipro Positioned as Leader in Everest Group – Life Sciences Digital Services PEAK Matrix™ Assessment

2020年02月26日 PM09:55
このエントリーをはてなブックマークに追加


 

BANGALORE, India

Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company, today announced that it has been positioned as a ‘Leader’ in Everest Group’s Life Sciences Digital Services PEAK Matrix™ Assessment 2019, globally.

Wipro has been investing in people, methods and technologies to help Life Sciences clients lead with innovation and deliver better health outcomes. The company has been enabling digital transformation across the value chain of pharma and medical device companies. In research and development (R&D), manufacturing & supply chain, commercial operations and drug safety regulation, Wipro leverages its power of cognitive computing, automation, robotics, cloud, analytics and rich domain expertise to serve clients.

This report analyses the capabilities of 23 IT service providers specific to the Life Sciences sector globally. These service providers are mapped on the Everest Group PEAK Matrix™, which is a composite index of a range of distinct metrics related to provider’s capability and market impact. The research focuses on: IT digital services market trends for Life Sciences, the landscape of service providers for Life Sciences digital services and assessment of the service providers on several capability and market success related dimensions.

Abhishek Singh, Vice President, Everest Group said, “Life Sciences enterprises expect their service providers to have strong digital and Life Sciences consulting skills to enable digital transformations. Wipro’s success in this market is due to its strategic acquisitions, skills and continued evolution of its value proposition to align to market needs.”

Steven Duryee, Vice President & Global Head, Life Sciences, Wipro Limited said, “The biopharma and medical technology industry is transforming traditional business models. It’s an era of great expectations, fleeting markets and global prospects, characterized by experience. Our vision for Life Sciences Digital Services is to address enterprise challenges such as care coordination, patient engagement, development of novel therapies, acceleration in all phases of drug & device development and reduction in the execution of studies, while keeping investigator and patient satisfaction at its core. Given that Everest Group PEAK Matrix™ reports are based, in part, on client feedback, we are especially happy to be recognized for our consulting, intellectual property and ability to deliver on complex digital transformations.”

The report with a focus on Wipro can be found here.

About Wipro Limited

Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO) is a leading global information technology, consulting and business process services company. We harness the power of cognitive computing, hyper-automation, robotics, cloud, analytics and emerging technologies to help our clients adapt to the digital world and make them successful. A company recognized globally for its comprehensive portfolio of services, strong commitment to sustainability and good corporate citizenship, we have over 175,000 dedicated employees serving clients across six continents. Together, we discover ideas and connect the dots to build a better and a bold new future.

Forward-looking and Cautionary Statements

Certain statements in this release concerning our future growth prospects are forward-looking statements, which involve a number of risks, and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in our earnings, revenue and profits, our ability to generate and manage growth, intense competition in IT services, our ability to maintain our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, the success of the companies in which we make strategic investments, withdrawal of fiscal governmental incentives, political instability, war, legal restrictions on raising capital or acquiring companies outside India, unauthorized use of our intellectual property, and general economic conditions affecting our business and industry. Additional risks that could affect our future operating results are more fully described in our filings with the United States Securities and Exchange Commission. These filings are available at www.sec.gov. We may, from time to time, make additional written and oral forward-looking statements, including statements contained in the company’s filings with the Securities and Exchange Commission and our reports to shareholders. We do not undertake to update any forward-looking statement that may be made from time to time by us or on our behalf.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200226005477/en/

CONTACT

Purnima Burman

Wipro Limited

purnima.burman@wipro.com

TimeLine:

同じカテゴリーの記事 

  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表
  • The Office of Health Economics: Adult Vaccination Programmes Deliver Socio-economic Benefits up to 19 Times Initial Investment, According to New Report
  • Masimo创始人兼首席执行官Joe Kiani将在智利举行的全球患者安全峰会上谈论人工智能
  • マシモ創業者兼最高経営責任者(CEO)のジョー・キアニがチリで開催される世界患者安全サミットでAIについて講演
  • Codone Biotech to Present Data on its Suppressor-tRNA Platform in Disease Models with Nonsense Mutations (Premature Termination Codons)